Preparing for the Post-Brexit Clinical Supply Chain
Pharma Industry, Regulatory
For clinical trial sponsors and clinical supply vendors with research in the United Kingdom (UK) and/or the European Union (EU), changes are coming. With the UK scheduled to leave the EU on March 29, 2019, understanding how this will affect the clinical supply chain is critical to supporting ongoing research. While political negotiations are ongoing, and the exact outcome is unclear, the research industry needs to prepare now.
Related Education Resources.
All ResourcesCovid-19 Supply Chain: Managing Risk & Disruption
Topics: Conference, COVID-19, Supply Chain
Executive Summary
Members
Envisioning the Future of Clinical Supply Chains in the Next 10 Years
Topic: Supply Chain
Executive Summary
Members
The Use of Direct-to-Patient Methods in Decentralized Clinical Trials in Israel
Topic: Direct-to-Patient
White Paper
Free
